Information for US Customers: Our dedicated website, sudoscan.us, is currently unavailable. For assistance, please feel free to contact us via email at admin@sudoscan.com or by phone at +18584502800.
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
News
Sudoscan in the “2016 Guidelines on the management of diabetic [...]
Press review
Article d’Armelle Bohineust – Paru dans le Figaro Economie le [...]
Events
SUDOSCAN was presented at the ALAD (Latin American Diabetes Association) [...]
News / Press review
14 Novembre 2016, Journée du Diabète Impeto Medical et [...]
Δ
April 20, 2025